528598-48-3

Upstream product

• 528598-67-6 (E)-3-[(1R,2R,7S)-2,7,9-Tris-benzyloxy-1-(2-[1,3]dithian-2-yl-ethyl)-nonyloxy]-acrylic acid ethyl ester 
• 528598-47-2 (3R,4R,9S)-4,9,11-Tris-benzyloxy-1-[1,3]dithian-2-yl-undecan-3-ol 
• 528598-45-0 (4R,5R)-4-((S)-5,7-Bis-benzyloxy-heptyl)-5-but-3-enyl-2,2-dimethyl-[1,3]dioxolane 
• 528598-40-5 [(4R,5R)-5-((S)-5,7-Bis-benzyloxy-hept-2-ynyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-methanol 
• 528598-43-8 [(4R,5R)-5-((S)-5,7-Bis-benzyloxy-heptyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-methanol 
• 528598-36-9 1-{[(S)-1-(Bbenzyloxy)hex-5-yn-3-yloxy]methyl}benzene 
• 115114-87-9 (2R)-2-(2-benzyloxyethyl)oxirane 
• 528598-35-8 (E)-3-[(1R,2R,7S)-2,7,9-Tris-benzyloxy-1-(3-oxo-propyl)-nonyloxy]-acrylic acid ethyl ester 

Downstream Products

• 528598-50-7 [(2R,3S,6R)-3-Hydroxy-6-((1R,6S)-1,6,8-tris-benzyloxy-octyl)-tetrahydro-pyran-2-yl]-acetic acid 
• 528598-51-8 (3aR,5R,7aR)-5-((1R,6S)-1,6,8-Tris-benzyloxy-octyl)-hexahydro-furo[3,2-b]pyran-2-one 
• 528598-52-9 (2R,3R,6R)-2-((E)-Dodec-2-enyl)-6-((1R,6S)-1,6,8-tris-benzyloxy-octyl)-tetrahydro-pyran-3-ol 
• 528598-55-2 (1R,6S)-8-(tert-Butyl-diphenyl-silanyloxy)-1-((2R,5R,6R)-6-dodecyl-5-methoxymethoxy-tetrahydro-pyran-2-yl)-octane-1,6-diol 
• 528598-62-1 (S)-3-[(Z)-(2R,8S,13R)-2-(tert-Butyl-diphenyl-silanyloxy)-13-((2R,5R,6R)-6-dodecyl-5-methoxymethoxy-tetrahydro-pyran-2-yl)-8,13-bis-methoxymethoxy-tridec-5-enyl]-5-methyl-5H-furan-2-one 
• 528598-63-2 (S)-3-[(2R,8R,13R)-2-(tert-Butyl-diphenyl-silanyloxy)-13-((2R,5R,6R)-6-dodecyl-5-methoxymethoxy-tetrahydro-pyran-2-yl)-8,13-bis-methoxymethoxy-tridecyl]-5-methyl-5H-furan-2-one 

Relevant academic research and scientific papers

Total synthesis of a cytotoxic acetogenin, pyranicin

(Matrix presented) The first total synthesis of a new cytotoxic acetogenin, pyranicin (1), is described. Sml2-induced reductive cyclization of β-alkoxy acrylate 4 proceeded stereoselectively to give 16,20-syn-19,20-trans-THP derivative 14, whic